RBC Capital Comments on BioMarin (BMRN) Following Prosensa (RNA) Deal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 56.54 +1.33 (2.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.21 | 52 Week High | $108.96 | |||
| Open | $55.40 | 52 Week Low | $62.12 | |||
| Day High | $56.56 | P/E | N/A | |||
| Day Low | $55.02 | EPS | $-1.27 | |||
| Volume | 902,707 | |||||
| PROSENSA HOLD (NASDAQ: RNA) | Delayed: 8.13 +0.13 (1.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.00 | 52 Week High | $22.80 | |||
| Open | $8.01 | 52 Week Low | $4.12 | |||
| Day High | $8.18 | P/E | N/A | |||
| Day Low | $7.95 | EPS | $0.00 | |||
| Volume | 78,612 | |||||
